I-A moleculeとは 意味・読み方・使い方

An organic compound having at least one of a partial structure represented by general formula (I) in a molecule is useful as this electric charge transport material.例文帳に追加

下記一般式（Ｉ）で表される部分構造を一分子内に１以上有する有機化合物。 - 特許庁

The method for producing the organosilane compound is provided by halogenating the molecule of formula (I) and reacting a silane derivative.例文帳に追加

分子（Ｉ）をハロゲン化し、シラン誘導体を反応させる上記有機シラン化合物の製法。 - 特許庁

This prepreg is obtained by impregnating (B) reinforcing fibers (preferably carbon fibers) with (A) an epoxy resin composition containing (i) an epoxy resin formulation containing an epoxy resin having a naphthalene skeleton in the molecule and 200-400 epoxy equivalents and coumpunded therein, (ii) dicyandiamide and (iii) a urea compound.例文帳に追加

次の構成要素［Ａ］、［Ｂ］、及び［Ｃ］を含むエポキシ樹脂組成物が強化繊維に含浸されてなるプリプレグ。 - 特許庁

A thermosetting composition for solder resist includes, as indispensable components, an epoxy resin (A) including two or more epoxy groups in a molecule, a polyacid anhydride (B) represented by a general formula (I) (wherein R represents a divalent organic group and (n) represents an integer of 2 to 30), and a coupling agent (C).例文帳に追加

本願発明に係るソルダーレジスト用熱硬化性組成物は、分子中に２個以上のエポキシ基を有するエポキシ樹脂（Ａ）、下記一般式（Ｉ）： - 特許庁

The present invention finds out the protein molecule having about 9,700 of molecular weight of which the concentration decreases gradually along with a progress of a stage from a I-stage to a II-stage, and a progress of a stage from the II-stage to a III-stage in the urine of a diabetic nephropathy patient.例文帳に追加

糖尿病性腎症患者の尿中で、I期からII期へ、II期からIII期へと病期が進行するにつれて、その濃度が徐々に減少する分子量約9,700のタンパク質分子を発見した。 - 特許庁

This composition is characterized by containing (A) a resin having an ethylene unsaturated group in the molecule and (B) an inclusion complex of an organic host molecule including a compound represented by formula (I).例文帳に追加

分子内にエチレン性不飽和基を有する樹脂（Ａ）、一般式（１）で表される化合物を包摂する有機ホスト分子の包摂複合体（Ｂ）を含有することを特徴とするエネルギー線硬化型樹脂組成物。 - 特許庁

The alignment layer is characterized in that it contains a polymer compound having a structure represented by general formula (I) in the molecule.例文帳に追加

分子中に、下記一般式（Ｉ）で表される構造を有する高分子化合物を含有することを特徴とする配向膜である。 - 特許庁

The invention provides a newly identified B7 receptor, zB7R1, that functions as lymphocyte inhibitory receptor, which is a PD-1-like molecule and is expressed on T cells.例文帳に追加

リンパ球抑制性受容体として機能し、PD-I様分子でありT細胞上に発現される新たに同定されたB7受容体、zB7R1。 - 特許庁